Crossmark

Normalization of electroretinogram and symptom resolution of melanoma-associated retinopathy with negative autoantibodies after treatment with programmed death-1 (PD-1) inhibitors for metastatic melanoma

Crossref DOI link: https://doi.org/10.1007/s00262-021-02875-x

Published Online: 2021-02-05

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khaddour, Karam

Khanna, Sangeeta

Ansstas, Michael

Jakhar, Ishaan

Dahiya, Sonika

Council, Laurin

Ansstas, George https://orcid.org/0000-0002-7178-8777
License Information

Text and Data Mining valid from 2021-02-05

Version of Record valid from 2021-02-05
More Information

Article History

Received: 10 August 2020

Accepted: 25 January 2021

First Online: 5 February 2021

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: Written informed consent was obtained from the patient for publication of this case report.

Document is current

Any future updates will be listed below